Duncan Edwards

  • Citations Per Year
Learn More
Atrial fibrillation confers a 5-fold increase in risk of stroke. A number of drugs aimed at reducing this risk have been tested in randomized controlled trials. These include antiplatelet agents (singly and in combination); anticoagulants, including vitamin K antagonists and direct thrombin inhibitors; and anticoagulants with antiplatelet agents. Guidelines(More)
PURPOSE Despite the compelling evidence supporting cardiovascular medications in the secondary prevention of coronary artery disease, many patients discontinue treatment. In this synthesis, we sought to understand from a patient perspective the factors that promote medication persistence. METHODS We systematically searched 7 databases (MEDLINE, Embase,(More)
BACKGROUND People who have a transient ischaemic attack (TIA) or minor stroke are at high risk of a recurrent stroke, particularly in the first week after the event. Early initiation of secondary prevention drugs is associated with an 80% reduction in risk of stroke recurrence. This raises the question as to whether these drugs should be given before being(More)
OBJECTIVES To explore the usage of the ABCD2 risk stratification score by general practitioners (GPs) and hospital staff during the referral of patients with suspected transient ischaemic attack (TIA) or minor stroke. DESIGN Qualitative study using semistructured interviews. SETTING Nine general practices and two hospital sites in England (Birmingham(More)
Malaz Abu Tarif Eric Aboagye Hisaka Akihiro Takashi Amisaki Melvin E. Andersen A. Bailer James Bailey Ludger Banken H. Banks James Bassingthwaighte Laurence Baxter Stuart L. Beal Misba Beerahee Bradley Bell J. Bennett D. Berk A. John Bailer Robert Bies Sven Björkman Alan Boddy Fredric Bois Peter Bonate F. Douglas Boudinot Michael Brier Richard Brundage(More)
In 1977 powers to charge those not 'ordinarily resident' in the UK for NHS care were first introduced, and rules governing eligibility for free NHS care have become increasingly complex since. In this issue (p. 156), Dubrey et al present an interpretation of the current regulations and express concern that the treatment of ineligible patients presents a(More)
  • 1